col0,col1,col2,col3,col4,col5,col6
NRAS Q61,cetuximab,melanoma,missense variant,NRAS,human chromosome 1,binimetinib
KRAS G12D,Panitumumab,lung cancer,missense variant,KRAS,human chromosome 12,MK-2206
KRAS G12C,gefitinib,lung cancer,missense variant,KRAS,human chromosome 12,selumetinib / docetaxel trihydrate combination therapy
RET M918T,motesanib,thyroid medullary carcinoma,missense variant,RET,human chromosome 10,sorafenib
